Philip Morris to Take $220 Million Loss on Sale of Inhaled-Medicine Unit 0 17.09.2024 17:29 The Wall Street Journal Philip Morris said it expects to record a loss on the sale of its inhaled-therapeutics unit to Molex Asia Holdings as it retools its pharmaceutical business. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
